https://www.gosh.nhs.uk/our-research/our-research-infrastructure/nihr-great-ormond-street-hospital-brc/brc-news/clinical-trial-new-stem-cell-based-therapy-rare-skin-condition-proves-promising/
Clinical trial for a new stem-cell based therapy for a rare skin condition proves promising
9 Sep 2015, 4:52 p.m.
Promising findings from a trial for a new stem-cell based therapy for a rare skin condition have been published in the Journal of Investigative Dermatology. The study, which involved intravenous injections of stem-cells, has led to an improvement in the quality of life for the subjects and their carers.Recessive dystrophic epidermolysis bullosa (RDEB) is an inherited skin disease which results in the severe blistering of the skin. It is caused by a mutation in the protein, COL7A1, which leads to reduced anchoring of the upper skin layers to deeper tissue. Currently there is no effective cure for this condition.
The clinical trial, which recruited 10 patients with RDEB, was led by Professor John McGrath at Kings College London and BRC-supported Principal Investigator Dr Anna Martinez at GOSH. The patients were followed up for one year following the stem cell infusions, which took place three times over a six month period. Questionnaires revealed an improvement in skin healing following blistering and a reduced pain score after therapy. The severity of the condition has also reported to be lessened.
Overall, the results from this study appear promising. While the patients in this study were not blinded, which the researchers’ state could lead to a positive bias towards the new treatment, patient benefits such as better sleep and reduced caring needs remains a positive from this study.
Read the full press release here.
Gene therapy offers potential to extend lives of children with rare immune disorder
Children have had their lives changed by a ground-breaking gene therapy treatment at Great Ormond Street Hospital for a rare immunodeficiency.
Cutting-edge genomic technology saves girl from rare brain infection
Great Ormond Street Hospital has launched the UK’s first accredited ‘metagenomics’ testing service, that allows clinicians to identify infections that are otherwise undetectable.
New research analyses key immune cell
A new study led by researchers at University College London Great Ormond Street Institute of Child Health has found that women have a higher proportion of key immune cells between puberty and menopause.
First patient treated with groundbreaking gene therapy trial
A baby boy born with a rare condition has become the first in the world to be treated with a new, potentially lifechanging, investigational gene therapy on a clinical trial at Great Ormond Street Hospital (GOSH).